MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced the pricing of its ...

Peters brings over 15 years of senior care and financial expertise to advance Care@Home 4 Life's mission of keeping seniors safely in the homes they love. Miami, FL, March 02, 2026 (GLOBE NEWSWIRE) -- ...

J.P. Morgan is acting as the underwriter for the offering.

Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received ...

Format: Fireside Chat and 1x1 Investor Meetings Date/Time: Monday, March 9, 2026, from 3:40 – 4:10 pm ET The presentation will be webcast live and archived in the Investor Relations section of ...

An archived replay of the webcast will be available on the Tenaya website for approximately 30 days following the conference. About Tenaya Therapeutics Tenaya Therapeutics is a clinical-stage ...

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility own ...

Konik Capital Partners LLC, a division of T.R. Winston & Company, is acting as the sole book-running manager for the offering. MAIA intends to use the net proceeds from the offering to conduct ...

The Precise MRD test is Myriad’s tumor-informed circulating tumor DNA (ctDNA) assay designed to support longitudinal monitoring during cancer treatment. Using whole-genome sequencing to create a ...

Tim Goodnow, PhD, President and Chief Executive Officer of Senseonics said, “In 2025, we took strategic actions to set the Company up for long term growth. Successfully bringing commercial operations ...

Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com. The webcast replays will be ...

Inducement Plan. Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a ...